Synaptive Medical

54 articles about Synaptive Medical

• Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors

  8/10/2023

  Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.

• Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D Activities

  8/2/2023

  Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund.

• Synaptive Announces U.S. and Canadian Availability of Next-Generation Robotic-Exoscope, Modus X

  3/22/2023

  Synaptive Medical Inc., a global medical technology innovator, announced FDA registration for the next-generation of its robotic exoscope.

• Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR

  10/11/2022

  Synaptive Medical Inc. announced a joint-development partnership with bioelectronic medicine company Panaxium SAS to incorporate Panaxium’s ultra-flexible iontronic electrocorticography platform into Synaptive’s Modus V robotic exoscope technology.

• Synaptive Medical Inc., Launches Dynamic Free Water Correction Feature to Enhance Planning and Navigation Technology

  10/6/2022

  Synaptive Medical Inc., a leader in automated brain mapping and enriched patient data, announced the launch of Reveal , a powerful new feature for its Modus™ Plan software.

• Synaptive Medical Appoints Mark Hanrahan as Chief Financial Officer

  5/25/2021

  Synaptive Medical, a leader in MRI and surgical robotics, has announced the appointment of Mark Hanrahan as Chief Financial Officer.

• ReGen Scientific First Health Institute in Canada to Introduce Evry™ into Proactive Brain Health Management and COVID-19 ‘Long-Hauler’ Research and Support

  2/10/2021

  ReGen Scientific, a leader in personalized, preventative, and regenerative health announced today it will become the first comprehensive health clinic in Canada to bring Synaptive Medical’s Evry™, a superconducting 0.5T head magnetic resonance imaging (MRI) system intended to provide MRI directly at the point-of-care, to their downtown Toronto location. 

• Synaptive Medical Announces Close of $17M Preferred Share Financing

  10/29/2020

  Funding to advance Synaptive’s suite of fully automated cranial and spinal equipment and software designed to optimize personalized patient care

• 

  BioSpace Movers & Shakers, July 10

  7/10/2020

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• Synaptive Medical Appoints Marc R. Buntaine as Chief Executive Officer

  7/7/2020

  Synaptive Medical, a leader in robotic surgical visualization, today announced the appointment of Marc R. Buntaine as chief executive officer.

• Synaptive Medical Secures FDA Clearance for Evry™FDA Clearance builds upon recent approval by Health Canada

  4/30/2020

  Synaptive Medical, a leader in robotic surgical visualization, announced today the company has secured clearance from the Food and Drug Administration (FDA) for its superconducting, head magnetic resonance imaging (MRI) technology, Evry™.

• Synaptive Medical Establishes Partnership with O-Two Medical Technologies, Inc., to Manufacture Ventilators for COVID-19 Patients

  4/27/2020

  Synaptive Medical, a leader in robotic surgical and imaging technologies, announced today the company has established a partnership with O-Two Medical Technologies, Inc., a world leader in controlled ventilation, for the production of O-Two’s e700 portable transport ventilator for patients impacted worldwide by COVID-19

• Synaptive Medical Secures Health Canada Approval for Evry™

  2/20/2020

  First-of-its-kind technology to provide broader access to magnetic resonance imaging (MRI) TORONTO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Synaptive Medical, a leader in robotic surgical visualization, announced today the company has secured approval from Health Canada for Evry™, the company’s superconducting, head MRI. Evry has been designed to provide imaging directly at the point of care in areas outside of diagnostic imaging departments, which was previously unachievable due to the size of c

• Synaptive Medical Announces Product Update to Flagship Surgical Technology, Modus VTM, Automated Robotic Microscope

  1/15/2020

  Synaptive Medical, a leader in robotic surgical visualization, announced today the U.S. and Canadian availability of updates to its flagship surgical technology product, Modus V, a fully automated robotic digital microscope designed to assist surgeons in the operating room for a seamless surgical workflow.

• Synaptive Medical Announces Close of $25M Preferred Share Financing and Elects Two New Board Members

  12/10/2019

  Synaptive Medical, a leader in automation and robotics, announced today it has completed the first round of a new preferred equity investment, totaling $25,000,000 USD.

• Synaptive Medical Announces Exhibition at Radiological Society of North America’s 2019 Scientific Assembly and Annual Meeting

  11/26/2019

  Synaptive Medical, a leader in automation and robotics, announced today it will highlight its products EvryTM, Modus PlanTM and ImageDriveTM at the Radiological Society of North America’s (RSNA) 2019 Scientific Assembly and Annual Meeting, which will convene at McCormick Place in Chicago, IL, from December 1-6.

• Synaptive Medical to Present at Upcoming American Medical Device 2019 Summit

  10/24/2019

  Synaptive Medical, a leader in automation and robotics, today announced that Cameron Piron, president and chief strategy officer of Synaptive Medical, will participate in this year’s American Medical Device Summit in Chicago on October 28 – 29, 2019

• Synaptive Medical Expands Availability of Modus V™ into Spine Market

  10/17/2019

  Synaptive Medical, a leader in automation and robotics, announced today a strategic commercial expansion into the spinal surgery market.

• 

  BioSpace Global Roundup, Aug. 8

  8/8/2019

  Biopharma companies from across the globe share business and development updates.

• Synaptive Medical to Present at the Canaccord Genuity 39th Annual Growth Conference

  8/7/2019

  Synaptive Medical Inc., a leader in transforming how surgeons access and use enriched patient data, announced today that Cameron Piron, President and Chief Strategy Officer, will present an overview of the Company and its business strategy during the Canaccord Genuity 39th Annual Growth Conference taking place August 7-8, 2019 in Boston, MA.